Asthma exercise

Article source Link

A new once-a-day drug to treat asthma and hay fever is to be tested in human trials for the first time.
The drug, RPL554, keeps the airways open, dampens down inflammation and protects against the irritants that trigger asthma.
Manufacturer Verona Pharma said trials would be conducted at the Centre for Human Drug Research in the Netherlands.
Research suggests that at least half of the 5.2 million people with asthma in the UK also have hay fever.
When the two conditions are combined the risk of asthma attacks and emergency hospital admissions increase

Natural asthma treatments

Power magazine

Free magazine

Suede headboard

Pink magazine